The estimated Net Worth of Elaine Ullian is at least $18 Million dollars as of 13 November 2017. Ms. Ullian owns over 12,774 units of Thermo Fisher Scientific stock worth over $16,885,195 and over the last 21 years she sold TMO stock worth over $773,355. In addition, she makes $341,266 as Independent Director at Thermo Fisher Scientific.
Elaine has made over 40 trades of the Thermo Fisher Scientific stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 12,774 units of TMO stock worth $240,407 on 13 November 2017.
The largest trade she's ever made was exercising 55,000 units of Thermo Fisher Scientific stock on 15 November 2005 worth over $604,450. On average, Elaine trades about 4,031 units every 40 days since 2003. As of 13 November 2017 she still owns at least 27,302 units of Thermo Fisher Scientific stock.
You can see the complete history of Ms. Ullian stock trades at the bottom of the page.
Elaine S. Ullian is Independent Director of the Company. She was the President and Chief Executive Officer of Boston Medical Center, a 550-bed academic medical center affiliated with Boston University, from July 1996 to her retirement in January 2010. Ms. Ullian is also a director of Vertex Pharmaceuticals, Inc. and Hologic Inc.
As the Independent Director of Thermo Fisher Scientific, the total compensation of Elaine Ullian at Thermo Fisher Scientific is $341,266. There are 16 executives at Thermo Fisher Scientific getting paid more, with Marc Casper having the highest compensation of $19,023,100.
Elaine Ullian is 71, she's been the Independent Director of Thermo Fisher Scientific since 2001. There are no older and 25 younger executives at Thermo Fisher Scientific.
Elaine's mailing address filed with the SEC is 35 CROSBY DRIVE, , BEDFORD, MA, 01730.
Over the last 21 years, insiders at Thermo Fisher Scientific have traded over $356,502,416 worth of Thermo Fisher Scientific stock and bought 4,301 units worth $223,007 . The most active insiders traders include Thomas J Lynch, Dion J Weisler, and Marc N Casper. On average, Thermo Fisher Scientific executives and independent directors trade stock every 23 days with the average trade being worth of $16,400,322. The most recent stock trade was executed by Marc N Casper on 3 September 2024, trading 20,000 units of TMO stock currently worth $4,213,600.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Thermo Fisher Scientific executives and other stock owners filed with the SEC include: